Skip to content

Pangenomic Study During Alcoholic Cirrhosis

Genetical Predisposition in Hepatocellular Carcinoma : Pangenomic Link Study During Alcoholic Cirrhosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01065233
Acronym
CDCHC
Enrollment
1325
Registered
2010-02-09
Start date
2008-10-23
Completion date
2013-07-20
Last updated
2021-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholic Cirrhosis

Brief summary

Hepatocellular carcinoma (HCC) is a frequent complication of cirrhosis. Occurrence of HCC could be linked with multiple functional region of genome. The determining of a genomic mapping of single nucleotide polymorphisms (SNPs) permit to perform some genetic link studies with pathologies without clear hereditary disposition. In this study, the investigators will identify predictives genetic polymorphism of HCC.

Interventions

DNA extraction of blood sample for DNAship analysis

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
35 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 35 to 70 years old * Compensated cirrhosis or not * Caucasian origin of the parents * Patient with cirrhosis (histological proof or obvious)

Exclusion criteria

* HIV, HBV, HCV positive * Known Homozygotia (C282Y+/+) * Important hepatocytary iron overload for patient with resection * HCC non histologically prooved

Design outcomes

Primary

MeasureTime frameDescription
Existence of HCC and Pangenomic analysis of DNA polymorphismExistence of HCC and determination of which genetic polymorphism are predisposing to HCC or preventing for HCC

Secondary

MeasureTime frameDescription
cirrhosis severity (compensated or not)Analysis of the genetic polymorphism involved in the severity of cirrhosis

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026